Ibogaine News & Articles

MAPS (Multidisciplinary Association for Psychedelic Studies) is a non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. Rick Doblin is a researcher at MAPS, and in “Psychedics can change humanity for the better. It’s time to unlock their power,” he delivers one of the most compelling cases for a range of psychedelics in helping those suffering from mental health and addiction issues.  Doblin and his team work …

Read Morepsychedelics can change humanity for the better its time to unlock their power

In 1962, a prominent scientist by the name of Howard Lotsof and his six friends decided to ingest ibogaine powder. The reason why? They were struggling mightily with heroin addiction and were on their last legs. The result – five of the six immediately quit heroin.  Far from a robust longitudinal study, the results fascinated many. Fast-forward to the present and we know ibogaine has the potential to ameliorate a host of maladies. We’re treated to a comprehensive summary of …

Read Moreibogaine for addiction treatment

Psychedelics have a long history in popular culture. Typically viewed as counter-culture, primarily due to their Schedule-1 classification in the US and a Class-A classification in the UK, psychedelics are not entirely legal as any savvy reader could tell you. With that said, we have certainly witnessed waves of psychedelic renaissances over the years. Yet, it would appear that the last 5 years have been different.  As Ed Prideaux details in “The worldview-changing drugs poised to go mainstream,” the difference …

Read Morewhat if everyone took psychedelics

Partnerships exist in all walks of life. But a collaborative project between the Osoyoos Indian Band (OIB) and a company called Universal Ibogaine might be the first of its kind.  Ibogaine has been a staple of many West African communities. Derived from the iboga shrub, its history as a spiritual sacrament is well-founded. But it wasn’t until the 1960s that practitioners began to experiment with ibogaine’s psychedelic components to treat a wide range of mental health and addiction issues. Universal …

Read Moreosoyoos indian band eyes cutting edge drug treatment centre

Despite global COVID shutdowns and declines in medical research funding not related to the pandemic, interest in psychedelic use to treat addictions and other psychological issues is booming.    The rise in popularity is happening in the business sector and beyond. While specific industries suffered economic blows due to COVID, notable psychedelic companies either went public or secured millions in funding. Currently, the U.S. Food and Drug Administration is conducting clinical trials involving psychedelic substances such as ibogaine, ketamine, and …

Read MorePsychedelic Interest Booms

University of California, Davis researchers have created a non-hallucinogenic version of ibogaine. The new substance could prove just as effective as the psychedelic original used to treat addiction and psychological illnesses such as depression and post-traumatic stress disorder. David Olson, an assistant professor of chemistry at UC Davis, detailed the discovery in the December 2020 issue of Nature.    In the study, a series of rodent experiments showed that mice decreased their alcohol consumption and experienced a delayed opiate relapse …

Read MoreScientists Develop Synthetic Form of Ibogaine

n the United States, over 2 million Americans suffered from opioid addiction in 2018. With relapse rates of traditional rehabilitative models averaging at about 50%, companies have positioned themselves within the psychedelic drug sector to bring a different therapeutic approach. Companies such as ATAI Sciences and DemeRx are investigating ibogaine, a natural extract found in western Central Africa that has proven effective in reducing opioid withdrawal symptoms and cravings. Researchers also found that the same substance lessens depression that accompanies …

Read MorePsychedelic Drug Attracts Corporate Attention

Researchers continue to examine the therapeutic properties of ibogaine as it proves effective in addiction rehabilitation. Countries such as New Zealand, Brazil, and South Africa allow it for medical use. In the United States, ibogaine is a Schedule 1 substance, which means it is not approved for medical use.  Ibogaine is an indole alkaloid produced by the Taberna iboga shrub native to West Africa. Traditionally, consumers used the substance to reduce fever, boost sexual arousal, and improve health. Specifically, it …

Read MoreIbogaine Attracts Addiction Research

Traditional rehabilitative models are failing to deliver results to those trying to beat chronic drug abuse. Some are hailing the increasing popular extract ibogaine for its suppressive effects on withdrawal symptoms and ultimately, addiction. Ibogaine, derived from a central west African shrub, is a psychedelic drug that has proven effective in treating alcohol, heroin, and opioid addiction in treatment centers worldwide. Scientists continue to study ibogaine to unlock its therapeutic power. One theory researchers have for ibogaine’s effectiveness is that …

Read MoreThe Promise of Ibogaine

Heroin and cocaine addiction is not only physically and psychologically harmful to the addict; the impact on family members, friends, and employment is equally destructive. Ibogaine, an indole alkaloid from the West African shrub, Tabernanthe iboga, has proven effective in treating a wide range of addictions. It is part of a larger alternative drug rehabilitation movement, and a fascinating study calling on 191 volunteers details its effectiveness.  Researchers concluded in “Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and …

Read MoreIbogaine PHARMACOLOGY